North Hollywood, CA, October 3, 2012 – This summer, the IMF formed the State Patients Equal Access Coalition (SPEAC), which is a patient-focused coalition representing patients, health care professionals, and cancer care centers, working collaboratively to ensure that cancer patients have appropriate access to a broad range of approved and medically-accepted anticancer regimens. Driven by the strategic plan of the national Patients Equal Access Coalition, SPEAC seeks to influence the development of insurance health exchanges in each state that will ensure an equal payment system and cost-sharing requirements for patients receiving intravenous, injectable, and/or orally-administered oncolytic therapies.
Member organizations of SPEAC include the American Cancer Society Cancer Action Network (ACS-CAN), Association of Community Cancer Centers (ACCC), National Brain Tumor Society, Susan G. Komen for the Cure Advocacy Alliance, the Leukemia & Lymphoma Society (LLS), and the Lymphoma Research Foundation (LRF).
This fall, the IMF advocacy team is laying the foundation to launch campaigns through SPEAC in New Jersey, Tennessee & Illinois in January 2013. Efforts will focus on bringing together the cancer community in those states, to work collaboratively, to ensure that implementation of the Affordable Care Act (ACA) includes affordable access to all health care services needed by cancer patients.
An initial coalition meeting was held in New Jersey on September 25th and going forward, the IMF will work with other organizations like the American Cancer Society, Susan G. Komen and others, in New Jersey, to impact the state’s choice of health plan for its state health exchange, Medicaid and other insurance products. The IMF is also hosting a meeting of the cancer community in Illinois in Springfield on Monday, November 26th and will launch similar efforts in Tennessee, by the end of the year.